Cargando…

Prediction of histone deacetylase inhibition by triazole compounds based on artificial intelligence

A quantitative structure-activity relationship (QSAR) study was conducted to predict the anti-colon cancer and HDAC inhibition of triazole-containing compounds. Four descriptors were selected from 579 descriptors which have the most obvious effect on the inhibition of histone deacetylase (HDAC). Fou...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yiran, Zhang, Peijian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10684768/
https://www.ncbi.nlm.nih.gov/pubmed/38035010
http://dx.doi.org/10.3389/fphar.2023.1260349
_version_ 1785151479718346752
author Wang, Yiran
Zhang, Peijian
author_facet Wang, Yiran
Zhang, Peijian
author_sort Wang, Yiran
collection PubMed
description A quantitative structure-activity relationship (QSAR) study was conducted to predict the anti-colon cancer and HDAC inhibition of triazole-containing compounds. Four descriptors were selected from 579 descriptors which have the most obvious effect on the inhibition of histone deacetylase (HDAC). Four QSAR models were constructed using heuristic algorithm (HM), random forest (RF), radial basis kernel function support vector machine (RBF-SVM) and support vector machine optimized by particle swarm optimization (PSO-SVM). Furthermore, the robustness of four QSAR models were verified by K-fold cross-validation method, which was described by Q ( 2 ). In addition, the R ( 2 ) of the four models are greater than 0.8, which indicates that the four descriptors selected are reasonable. Among the four models, model based on PSO-SVM method has the best prediction ability and robustness with R ( 2 ) of 0.954, root mean squared error (RMSE) of 0.019 and Q ( 2 ) of 0.916 for the training set and R ( 2 ) of 0.965, RMSE of 0.017 and Q ( 2 ) of 0.907 for the test set. In this study, four key descriptors were discovered, which will help to screen effective new anti-colon cancer drugs in the future.
format Online
Article
Text
id pubmed-10684768
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-106847682023-11-30 Prediction of histone deacetylase inhibition by triazole compounds based on artificial intelligence Wang, Yiran Zhang, Peijian Front Pharmacol Pharmacology A quantitative structure-activity relationship (QSAR) study was conducted to predict the anti-colon cancer and HDAC inhibition of triazole-containing compounds. Four descriptors were selected from 579 descriptors which have the most obvious effect on the inhibition of histone deacetylase (HDAC). Four QSAR models were constructed using heuristic algorithm (HM), random forest (RF), radial basis kernel function support vector machine (RBF-SVM) and support vector machine optimized by particle swarm optimization (PSO-SVM). Furthermore, the robustness of four QSAR models were verified by K-fold cross-validation method, which was described by Q ( 2 ). In addition, the R ( 2 ) of the four models are greater than 0.8, which indicates that the four descriptors selected are reasonable. Among the four models, model based on PSO-SVM method has the best prediction ability and robustness with R ( 2 ) of 0.954, root mean squared error (RMSE) of 0.019 and Q ( 2 ) of 0.916 for the training set and R ( 2 ) of 0.965, RMSE of 0.017 and Q ( 2 ) of 0.907 for the test set. In this study, four key descriptors were discovered, which will help to screen effective new anti-colon cancer drugs in the future. Frontiers Media S.A. 2023-11-15 /pmc/articles/PMC10684768/ /pubmed/38035010 http://dx.doi.org/10.3389/fphar.2023.1260349 Text en Copyright © 2023 Wang and Zhang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Wang, Yiran
Zhang, Peijian
Prediction of histone deacetylase inhibition by triazole compounds based on artificial intelligence
title Prediction of histone deacetylase inhibition by triazole compounds based on artificial intelligence
title_full Prediction of histone deacetylase inhibition by triazole compounds based on artificial intelligence
title_fullStr Prediction of histone deacetylase inhibition by triazole compounds based on artificial intelligence
title_full_unstemmed Prediction of histone deacetylase inhibition by triazole compounds based on artificial intelligence
title_short Prediction of histone deacetylase inhibition by triazole compounds based on artificial intelligence
title_sort prediction of histone deacetylase inhibition by triazole compounds based on artificial intelligence
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10684768/
https://www.ncbi.nlm.nih.gov/pubmed/38035010
http://dx.doi.org/10.3389/fphar.2023.1260349
work_keys_str_mv AT wangyiran predictionofhistonedeacetylaseinhibitionbytriazolecompoundsbasedonartificialintelligence
AT zhangpeijian predictionofhistonedeacetylaseinhibitionbytriazolecompoundsbasedonartificialintelligence